Soluble CD14 (sCD14) 18, 42 and 162 hours after segmental allergen challenge in atopic asthmatics

P. Julius, C. Grosse-Thie, K. Michael, B. Kai, F. Sebastian, W. Luttmann, J. C. Virchow (Rostock, Germany)

Source: Annual Congress 2005 - Mechanisms of inflammatory reactions in asthma, COPD and models of allergic airway disease
Session: Mechanisms of inflammatory reactions in asthma, COPD and models of allergic airway disease
Session type: Thematic Poster Session
Number: 3740
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Julius, C. Grosse-Thie, K. Michael, B. Kai, F. Sebastian, W. Luttmann, J. C. Virchow (Rostock, Germany). Soluble CD14 (sCD14) 18, 42 and 162 hours after segmental allergen challenge in atopic asthmatics. Eur Respir J 2005; 26: Suppl. 49, 3740

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Bronchoalveolar cells 10 min, 18, 42 and 126 h after segmental allergen challenge in allergic asthmatics
Source: Eur Respir J 2003; 22: Suppl. 45, 479s
Year: 2003

CCR4 ligands are up-regulated in the airways of atopic asthmatics after segmental allergen challenge
Source: Eur Respir J 2004; 23: 876-884
Year: 2004



Reduction of IL-5 receptor on BAL eosinophils 18 h and on blood eosinophils 42 h after allergen challenge
Source: Eur Respir J 2001; 18: Suppl. 33, 531s
Year: 2001

Expression of CCR3 in bronchial biopsies after allergen challenge in subjects with atopic asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 5s
Year: 2002

Total IgE and Der p 1 (D1) specific IgE in induced sputum (IS) in patients with allergic and non-allergic asthma
Source: International Congress 2018 – Biomarkers for evaluating asthma
Year: 2018


Chemokine and cytokine production in the airway from atopic asthmatics after segmental allergen challenge
Source: Eur Respir J 2003; 22: Suppl. 45, 378s
Year: 2003

A monoclonal antibody to IL-1B attenuates the late asthmatic response to antigen challenge in patients with mild asthma
Source: Annual Congress 2006 - Novel treatments for asthma
Year: 2006


Late-breaking abstract: Interleukin 17 expression and peripheral blood neutrophils chemotaxis in patients with allergic rhinitis and asthma challenged with D. pteronyssinus
Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New mechanisms in airway disease
Year: 2011

Association of asthma and total IgE levels with human leucocyte antigen-DR in patients with grass allergy
Source: Eur Respir J 2002; 20: 79-85
Year: 2002



The toll-like receptor (TLR) 5 ligand, flagellin, prometes asthma by priming allergic responses to indoor allergens
Source: Annual Congress 2011 - Asthma mechanisms
Year: 2011



Local and systemic inflammatory responses following bronchial instillation of house dust mite allergen (HDM) and HDM/lipopolysaccharide (LPS) in mild asthmatics
Source: Annual Congress 2011 - Mechanisms of allergic inflammation of the airways
Year: 2011

Levels of pro-inflammatory cytokines and NO in atopic (AA), non atopic asthmaticus (NAA) and healthy children
Source: Eur Respir J 2004; 24: Suppl. 48, 596s
Year: 2004

Soluble CD40 ligand and soluble P-selectin in allergic asthma patients during exercise-induced bronchoconstriction
Source: Annual Congress 2007 - New mechanisms in the pathogenesis of asthma and allergy
Year: 2007


Local coagulation activation following bronchial instillation of house dust mite allergen (HDM) and HDM/Lipopolysaccharide (LPS) in mild asthmatics
Source: Annual Congress 2012 - Different ways to phenotype asthma
Year: 2012

Correlation of plasma IL-5 with sputum and blood eosinophils and ECP following a single nasal allergen challenge in non-asthmatic subjects with seasonal allergic rhinitis
Source: Eur Respir J 2002; 20: Suppl. 38, 217s
Year: 2002

Interaction between eotaxin and IL-13 in serum and sputum: comparison between normal and allergic asthmatic children
Source: Eur Respir J 2004; 24: Suppl. 48, 396s
Year: 2004

Reduced late asthmatic response by repeated low-dose allergen exposure
Source: Eur Respir J 2001; 17: 872-880
Year: 2001



The contents of α1-acid glycoprotein (α1-AGP) and metabolites of nitric oxide (NO) in nasal lavage fluid (NLF) of patients with bronchial asthma (BA) and allergic rhinitis (AR) and house dust mites (HDM) exposure
Source: Eur Respir J 2001; 18: Suppl. 33, 43s
Year: 2001

YKL-40 in asthmatic patients, and its correlations with exacerbation, eosinophils and immunoglobulin E
Source: Eur Respir J 2010; 35: 757-760
Year: 2010



Ciclesonide 80 μg once daily reduces early and late asthmatic reaction, sputum eosinophils and serum ECP in asthma patients challenged with allergens
Source: Eur Respir J 2005; 26: Suppl. 49, 254s
Year: 2005